Comprehensive molecular characterization of gastric adenocarcinoma
Explore this paper's citation graph
Summary
A comprehensive molecular evaluation of 295 primary gastric adenocarcinomas as part of The Cancer Genome Atlas (TCGA) project is described and a molecular classification dividing gastric cancer into four subtypes is proposed.
- Type
- article
- Published
- 2014-07-23
- Cited by
- 6,030
- References
- 80
- Access
- Open access
- OpenAlex
- https://openalex.org/W2126547130
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:560132
Keywords
Microsatellite instability, Cancer research, Chromosome instability, Biology, Cancer
References
- The STATs of cancer — new molecular targets come of age
- Integrated Genomic Characterization of Endometrial Carcinoma
- WHO Classification of Tumours of the Digestive System
- Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location
- Differences in Gastric Carcinoma Microenvironment Stratify According to EBV Infection Intensity: Implications for Possible Immune Adjuvant Therapy
- SPARSE INTEGRATIVE CLUSTERING OF MULTIPLE OMICS DATA SETS
- MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict Survival and Respond Differently to Chemotherapy
- PathSeq: A comprehensive computational tool for the identification or discovery of microorganisms by deep sequencing of human tissue
- Stimulation of Membrane Ruffling and MAP Kinase Activation by Distinct Effectors of RAS
- Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
- Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals.
- High density DNA methylation array with single CpG site resolution.
- Pattern discovery and cancer gene identification in integrated cancer genomic data
- Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype.
- Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2
- Physiological roles of Rho and Rho effectors in mammals.
- Analysis for microsatellite instability and mutations of the DNA mismatch repair gene hMLH1 in familial gastric cancer
- Integrated detection and population-genetic analysis of SNPs and copy number variation
Cited by
- Upregulated, 7q21-22 amplicon candidate gene SHFM1 confers oncogenic advantage by suppressing p53 function in gastric cancer.
- Neoadjuvant chemoradiation therapy for resectable esophago-gastric adenocarcinoma: a meta-analysis of randomized clinical trials
- Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
- Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation
- Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma
- Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer
- Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer.
- Pathogenic enablers — toxic relationships in the stomach
- Studying Cancer Evolution in Barrett's Esophagus and Esophageal Adenocarcinoma.
- Programmed Death-Ligand 1 Expression, Microsatellite Instability, Epstein–Barr Virus, and Human Papillomavirus in Nasopharyngeal Carcinomas of Patients from the Philippines
- Gastric cancer management: Kinases as a target therapy
- Integrated expression analysis identifies transcription networks in mouse and human gastric neoplasia
- Expression of NUAK2 in gastric cancer tissue and its effects on the proliferation of gastric cancer cells.
- Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways
- EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?
- Current Targeted Therapies in HER2-Positive Gastric Adenocarcinoma
- Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial
- Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
- DNA methylation biomarkers for head and neck squamous cell carcinoma
Related papers
- Overexpression of RhoA promotes the proliferation and migration of cervical cancer cells
- Function of the post-translationally modified C-terminal region of rho p21.
- Tyr42 phosphorylation of RhoA GTPase promotes tumorigenesis through nuclear factor (NF)-κB.
- Quantitation of RhoA activation: differential binding to downstream effectors
- RhoA regulates Schwann cell differentiation through JNK pathway
- RhoA‐dependent tight junction regulation is associated with dysregulated Akt and ERK signaling and increased claudin‐2 expression
- Clinicopathologic Characteristics, CpG Island Methylator Phenotype, and BRAF Mutations in Microsatellite-Stable Colorectal Cancers Without Chromosomal Instability
- Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification.